Polar Capital Holdings’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,314
Closed -$233K 280
2023
Q3
$233K Sell
5,314
-10,101
-66% -$493K ﹤0.01% 276
2023
Q2
$761K Hold
15,415
﹤0.01% 266
2023
Q1
$639K Sell
15,415
-2,984
-16% -$124K ﹤0.01% 273
2022
Q4
$817K Sell
18,399
-554,946
-97% -$23.2M 0.01% 277
2022
Q3
$22.4K Buy
573,345
+44,487
+8% +$2.04M 0.14% 134
2022
Q2
$21.6K Hold
528,858
0.13% 138
2022
Q1
$34.7K Buy
528,858
+2,100
+0.4% +$136K 0.16% 117
2021
Q4
$36.6K Buy
526,758
+10,848
+2% +$789K 0.14% 124
2021
Q3
$35.9K Buy
515,910
+203,720
+65% +$15.7M 0.15% 125
2021
Q2
$24.8K Sell
312,190
-195,796
-39% -$14.2M 0.11% 150
2021
Q1
$33.3M Buy
507,986
+96,010
+23% +$5.91M 0.21% 119
2020
Q4
$22.9M Buy
+411,976
New +$17.8M 0.14% 141

Other funds holding ATRC

Polar Capital Holdings's ATRC Position: Q4 2023 in Review

Polar Capital Holdings sold out of AtriCure (ATRC) in Q4 2023, closing a stake of 5,314 shares — an estimated $233K sold.

Polar Capital Holdings first reported a position in ATRC in Q4 2020 and held it in 12 quarters. The position peaked at $33.3M in Q1 2021. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2023.

  • Polar Capital Holdings reported no remaining AtriCure position as of Q4 2023 after selling out during the quarter.
  • Polar Capital Holdings sold 5,314 AtriCure shares in Q4 2023, an estimated $233K.
  • Polar Capital Holdings first reported a position in AtriCure in Q4 2020 and held it in 12 quarters.
  • Polar Capital Holdings's AtriCure position peaked at $33.3M in Q1 2021.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2023.

Based on Polar Capital Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.